Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 66th Annual Meeting and Exposition. This year’s meeting will be held in San Diego Dec. 7-10. 

Widely considered the world’s leading event in malignant and non-malignant hematology, ASH has sponsored the annual meeting for more than 60 years. The scientific program features presentations and data updates, including diagnostic developments and other advances in hematology.

UCSF scientists developed a way to deliver radiation just to cancerous cells, rather than attacking both cancerous and healthy tissue. The therapy combines a drug to mark the cancer cells for destruction and a radioactive antibody to kill them.

A newly developed “molecular GPS” to guide immune cells into the brain and kill tumors without harming healthy tissue is the first living cell therapy that can navigate through the body to a specific organ.

A new technology uses engineered T cells that act as immune “referees” to soothe overreacting immune responses. They also can mop up inflammatory molecules without lowering the entire body’s immune shields.

UCSF scientists are uncovering the brain mechanisms behind resilience to stress and exploring new, non-invasive treatments for depression through groundbreaking research in mice.

The National AIDS Memorial has honored Dan Bernal, UCSF vice chancellor for community and government relations, for his lifelong contributions to health equity and community service through HIV activism and advocacy.

Something is blooming above the Parnassus Heights campus – where scientists are accelerating research to treat the world’s most devastating diseases.

Pediatric cardiac ICU nurse Kathleen Cinelli, RN, created the Hearts at Home Program, offering holistic care to UCSF Health patients and families beyond the hospital.

Drinking enough water can help with weight loss and prevent kidney stones, as well as migraines, urinary tract infections and low blood pressure.